[go: up one dir, main page]

ZA925726B - Novel N-alkylated 1,4-dihydropyridinedicarboxylic acid esters. - Google Patents

Novel N-alkylated 1,4-dihydropyridinedicarboxylic acid esters.

Info

Publication number
ZA925726B
ZA925726B ZA925726A ZA925726A ZA925726B ZA 925726 B ZA925726 B ZA 925726B ZA 925726 A ZA925726 A ZA 925726A ZA 925726 A ZA925726 A ZA 925726A ZA 925726 B ZA925726 B ZA 925726B
Authority
ZA
South Africa
Prior art keywords
acid esters
alkylated
novel
dihydropyridinedicarboxylic
dihydropyridinedicarboxylic acid
Prior art date
Application number
ZA925726A
Other languages
English (en)
Inventor
Bruno Rosen
Siegfried Zaiss
Harmund Wollweber
Jonge Maarten De
Hans-Georg Dellweg
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA925726B publication Critical patent/ZA925726B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA925726A 1991-07-31 1992-07-30 Novel N-alkylated 1,4-dihydropyridinedicarboxylic acid esters. ZA925726B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125271A DE4125271A1 (de) 1991-07-31 1991-07-31 Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Publications (1)

Publication Number Publication Date
ZA925726B true ZA925726B (en) 1993-03-10

Family

ID=6437351

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925726A ZA925726B (en) 1991-07-31 1992-07-30 Novel N-alkylated 1,4-dihydropyridinedicarboxylic acid esters.

Country Status (18)

Country Link
US (1) US5328931A (da)
EP (1) EP0525568B1 (da)
JP (1) JPH05194395A (da)
KR (1) KR930002316A (da)
AT (1) ATE122341T1 (da)
AU (1) AU646349B2 (da)
CA (1) CA2074777A1 (da)
CZ (1) CZ233492A3 (da)
DE (2) DE4125271A1 (da)
DK (1) DK0525568T3 (da)
ES (1) ES2072666T3 (da)
FI (1) FI923423L (da)
HU (1) HUT65434A (da)
IE (1) IE922512A1 (da)
IL (1) IL102670A0 (da)
MX (1) MX9204238A (da)
NO (1) NO177094B (da)
ZA (1) ZA925726B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
ES2096179T3 (es) * 1992-10-30 1997-03-01 Bayer Ag Dihidropiridinas sustituidas en la posicion 4 con un heterociclilfenilo.
DE59410255D1 (de) 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4342195A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Dihydropyridine mit heterocyclisch substituierten Estern
DE4430092A1 (de) * 1994-08-25 1996-02-29 Bayer Ag 2,3-Cyclisch kondensierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2003099790A1 (en) * 2002-05-29 2003-12-04 Council Of Scientific And Industrial Research Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
US11512052B2 (en) 2017-11-21 2022-11-29 Icahn School Of Medicine At Mount Sinai Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2210667A1 (de) * 1972-03-06 1973-09-20 Bayer Ag Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
DK142287A (da) * 1986-03-27 1987-09-28 Byk Gulden Lomberg Chem Fab Optisk aktive 1,4-dihydropyridinderivater
FR2596760B1 (fr) * 1986-04-02 1988-12-09 Sori Soc Rech Ind Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique
EP0322747B1 (en) * 1987-12-29 1994-03-02 Fujisawa Pharmaceutical Co., Ltd. A brain neuron protecting agent containing a dihydropyridine compound
AU650567B2 (en) * 1988-09-06 1994-06-23 Davis, Warren L. Dental syringe tip and adaptor
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DK0525568T3 (da) 1995-10-09
IE922512A1 (en) 1993-02-10
AU646349B2 (en) 1994-02-17
NO177094B (no) 1995-04-10
CZ233492A3 (en) 1993-05-12
ATE122341T1 (de) 1995-05-15
KR930002316A (ko) 1993-02-22
FI923423A7 (fi) 1993-02-01
MX9204238A (es) 1993-01-01
NO922852D0 (no) 1992-07-17
HUT65434A (en) 1994-06-28
FI923423A0 (fi) 1992-07-29
FI923423L (fi) 1993-02-01
DE4125271A1 (de) 1993-02-11
EP0525568A1 (de) 1993-02-03
EP0525568B1 (de) 1995-05-10
US5328931A (en) 1994-07-12
HU9202489D0 (en) 1992-10-28
IL102670A0 (en) 1993-01-14
DE59202132D1 (de) 1995-06-14
JPH05194395A (ja) 1993-08-03
NO922852L (no) 1993-02-01
AU2048392A (en) 1993-02-04
ES2072666T3 (es) 1995-07-16
CA2074777A1 (en) 1993-02-01

Similar Documents

Publication Publication Date Title
GR3027787T3 (en) Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives.
ZA907338B (en) Thienylcarboxylates of amino alcohols
ZA925726B (en) Novel N-alkylated 1,4-dihydropyridinedicarboxylic acid esters.
PH31375A (en) Antimicrobial quinolonyl lactam esters.
SE8600017D0 (sv) New compound
GR3019774T3 (en) Piperidylmethyl substituted chroman derivatives as agents for the treatment of diseases of the central nervous system
ATE81491T1 (de) Plastifizierungsmittel, verfahren zu seiner herstellung sowie seine verwendung.
TW241264B (da)
GR3024295T3 (en) 4-heterocycle substituted dihydropyridines
DK0657432T3 (da) Phenylsubstituerede 1,4-dihydropyridiner med cerebral aktivitet
GR3001719T3 (en) Process for preparing optically active carbonyl compounds
CS167288A1 (en) Process for preparing 1,3,5-triazines on the base of acetoacetic acid arylide
DE59404408D1 (de) Verfahren zur Herstellung von Isocyansäure aus Cyanursäure
MY106269A (en) Novel antimicrobial quinolonyl lactam esters.
IT1223071B (it) Composizione poliolefinica per stampaggio